|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
Irinotecan Plus Gemcitabine
Results in No Survival Advantage Compared with Gemcitabine Monotherapy
in Patients with Locally Advanced or Metastatic Pancreatic Cancer
Despite Increased Tumor Response Rate J Clin Oncol. 2004 Sep 15;22(18):3776-83. PMID: 15365074
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |